Previous Article | Next Article ![]()
Clinical Microbiology Reviews, October 2003, p. 597-621, Vol. 16, No. 4
0893-8512/03/$08.00+0 DOI: 10.1128/CMR.16.4.597-621.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104
Patients with defects in phagocytic function are predisposed to intracellular microorganisms and typically have early dissemination of the infection. Recognition of the underlying disorder and aggressive antimicrobial therapy has been beneficial for the patients. Improved understanding of the pathophysiology has also affected patient management by allowing specific, targeted immunomodulatory intervention. The disorders described in this review are not common but have had a significant impact on our understanding of the role of phagocytic cells in host defense. Conversely, understanding the role of the neutrophil and macrophage in infection has benefited not just the patients described in this review but also other patients with similar disease processes.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Vaccine Immunol. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |